Online Only Articles

Usefulness of initial plasma dabigatran concentration to predict rebound after reversal

AP-HP, European Hospital Georges Pompidou, Hematology Department, Paris, France;Université Paris Descartes, Sorbonne Paris Cite, Paris, France;Inserm UMR-S1140, Paris, France
AP-HP, European Hospital Georges Pompidou, Hematology Department, Paris, France;Université Paris Descartes, Sorbonne Paris Cite, Paris, France
AP-HP, European Hospital Georges Pompidou, Regional Center of Pharmacovigilance, Paris, France
AP-HP, European Hospital Georges Pompidou, Hematology Department, Paris, France;Université Paris Descartes, Sorbonne Paris Cite, Paris, France;Inserm UMR-S1140, Paris, France
AP-HP, European Hospital Georges Pompidou, Regional Center of Pharmacovigilance, Paris, France
AP-HP, European Hospital Georges Pompidou, Hematology Department, Paris, France;Université Paris Descartes, Sorbonne Paris Cite, Paris, France;Inserm UMR-S1140, Paris, France
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.183400